Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claire Vesin is active.

Publication


Featured researches published by Claire Vesin.


Atherosclerosis | 2009

Predictive factors for all-cause mortality in the hospitalized elderly subject: The importance of arrhythmia

Claire Vesin; Athanase D. Protogerou; Ari Lieber; Hélène Safar; Pierre Iaria; Pierre Ducimetière; Michel E. Safar; Jacques Blacher

BACKGROUND In elderly patients traditional cardiovascular (CV) risk factors are poorly correlated with mortality and few data are available on determinants and consequences of supra-ventricular arrhythmia. In a cohort of 331 hospitalized elderly patients (mean age+/-SD=85+/-7 years), we assessed which CV characteristics were associated with all-cause mortality. AIM OF THE STUDY We wished to determine whether the presence of arrhythmia was associated with an increase of overall mortality in the hospitalized elderly population, and to ascertain which factors were associated with arrhythmia, in order to better understand the underlying mechanisms of both arrhythmia and arrhythmia-related mortality in these patients. RESULTS The relative hazard for overall mortality in the presence of arrhythmia was 2.40 (95% CI: 1.41-4.07; p<0.001), independent of major confounding factors, compared to sinus rhythm. Both arrhythmia and low DBP were independent predictors of mortality but no association or interaction between arrhythmia and DBP was observed. The left atrium diameter was found to be a predictor of arrhythmia, and when entered in the Cox regression analysis, it suppressed arrhythmia from the model predicting all-cause mortality. CONCLUSION In the hospitalized elderly, arrhythmia is an independent predictor of all-cause mortality, and left atrium size is an independent predictor of both arrhythmia and mortality, suggesting that links exist. Therapeutic management could therefore focus more on prevention of heart structure remodelling than on traditional risk factors.


Hypertension | 2007

Brachial Pulse Pressure and Cardiovascular Risk

Jacques Blacher; Michel E. Safar; Claire Vesin; Annie Rudnichi

To the Editor: The study by Mosley et al1 shows in a large population that, in the predictive value of cardiovascular (CV) risk, pulse pressure (PP) is less effective than systolic (SBP) or diastolic blood pressure (BP). This finding supports the usual approach of major current guidelines but also raises major questions related to SBP and PP (here measured exclusively at the site of the brachial artery). First, the classification into SBP or PP reflects, in fact, a particular approach in the clinical management of CV risk. The former …


Atherosclerosis | 2008

Pulse pressure amplification, adiposity and metabolic syndrome in subjects under chronic antihypertensive therapy : The role of heart rate

Anne Claire Vergnaud; Athanase D. Protogerou; Yan Li; Sébastien Czernichow; Claire Vesin; Jacques Blacher; Michel E. Safar


European Journal of Preventive Cardiology | 2010

Control of baseline cardiovascular risk factors in the SU-FOL-OM3 study cohort: does the localization of the arterial event matter?:

Claire Vesin; Pilar Galan; Benoit Gautier; Sébastien Czernichow; Serge Hercberg; Jacques Blacher


Sang Thrombose Vaisseaux | 2009

Facteurs de risque vasculaire chez la femme

Adèle Nana Singuim; Claire Vesin; Michel E. Safar; Jacques Blacher


Sang Thrombose Vaisseaux | 2007

Homocystéine et risque cardiovasculaire

Claire Vesin; Marie-Hélène Horellou; Sandrine Mairesse; Jacqueline Conard; Michel E. Safar; Jacques Blacher


Journal Des Maladies Vasculaires | 2009

La vitesse de l’onde de pouls augmente avec le nombre de critères du syndrome métabolique

Ari Lieber; Claire Vesin; V. Cahen; A. Nana; Michel E. Safar; Bernard I. Levy; Jacques Blacher


Journal Des Maladies Vasculaires | 2009

Amplification de la pression artérielle, tour de taille et syndrome métabolique

Ari Lieber; Claire Vesin; A. Nana; V. Cahen; Michel E. Safar; Bernard I. Levy; Jacques Blacher


Journal Des Maladies Vasculaires | 2008

Homocystéine plasmatique : quand la doser et pour quoi faire ?

Jacques Blacher; Claire Vesin; S. Mairesse


Archive | 2007

Efficacit de lacide folique dans la prvention crbrovasculaire

Claire Vesin; Sophie Mairesse; Pierre Iaria; Jacques Blacher

Collaboration


Dive into the Claire Vesin's collaboration.

Top Co-Authors

Avatar

Jacques Blacher

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

Michel E. Safar

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

Ari Lieber

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

Pierre Iaria

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

S. Mairesse

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Annie Rudnichi

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

Athanase D. Protogerou

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge